Christopher M. Dunn

Christopher M. Dunn

Auto-generated profile, based on publicly available information

Christopher M. Dunn

Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program and University of Oklahoma Health Sciences Center Oklahoma City

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in Current Rheumatology Reports
Verified
Journal Article
Closed access
PDF file
CDChristopher M. Dunn
Christopher M. Dunn
MJMatlock A. Jeffries
Matlock A. Jeffries


12 December 2023 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
LSLeoni Schlupp
Leoni Schlupp
EPEmmaline Prinz
Emmaline Prinz
GDGabriella Dyson
Gabriella Dyson
MBMontana Barrett
Montana Barrett
VIVladislav Izda
Vladislav Izda
MJMatlock A. Jeffries
Matlock A. Jeffries

9 November 2023 in GeroScience
Verified
Journal Article
Open access
PDF file
VIVladislav Izda
Vladislav Izda
LSLeoni Schlupp
Leoni Schlupp
EPEmmaline Prinz
Emmaline Prinz
GDGabby Dyson
Gabby Dyson
MBMontana Barrett
Montana Barrett
MJMatlock A. Jeffries
Matlock A. Jeffries
Cartilage microbial DNA patterns have been recently characterized in osteoarthritis (OA). The objectives of this study were to evaluate the gut origins of cartilage microbial DNA, to characterize cartilage microbial changes with age, obesity, and OA in mice, and correlate these to gut microbiome changes. We used 16S rRNA sequencing performed longitudinally on articular knee cartilage from germ-free (GF) mice following oral microbiome inoculation and cartilage and cecal samples from young and old wild-type mice with/without high-fat diet-induced obesity (HFD) and with/without OA induced by destabilization of the medial meniscus (DMM) to evaluate gut and cartilage microbiota. Microbial diversity was assessed, groups compared, and functional metagenomic profiles reconstructed. Findings were confirmed in an independent cohort by clade-specific qPCR. We found that cartilage microbial patterns developed at 48 h and later timepoints following oral microbiome inoculation of GF mice. Alpha diversity was increased in SPF mouse cartilage samples with age (P = 0.013), HFD (P = 5.6E-4), and OA (P = 0.029) but decreased in cecal samples with age (P = 0.014) and HFD (P = 1.5E-9). Numerous clades were altered with aging, HFD, and OA, including increases in Verrucomicrobia in both cartilage and cecal samples. Functional analysis suggested changes in dihydroorotase, glutamate-5-semialdehyde dehydrogenase, glutamate-5-kinase, and phosphoribosylamine-glycine ligase, in both cecum and cartilage, with aging, HFD, and OA. In conclusion, cartilage microbial DNA patterns develop rapidly after the introduction of a gut microbiome and change in concert with the gut microbiome during aging, HFD, and OA in mice. DMM-induced OA causes shifts in both cartilage and cecal microbiome patterns independent of other factors.

17 October 2022 in ACR Open Rheumatology
Verified
Journal Article
Open access
VIVladislav Izda
Vladislav Izda
CDChristopher M. Dunn
Christopher M. Dunn
EPEmmaline Prinz
Emmaline Prinz
LSLeoni Schlupp
Leoni Schlupp
ENEmily Nguyen
Emily Nguyen
MJMatlock A. Jeffries
Matlock A. Jeffries
Objective: Cartilage epigenetic changes are strongly associated with human osteoarthritis (OA). However, the influence of individual environmental OA risk factors on these epigenetic patterns has not been determined; herein we characterize cartilage DNA methylation patterns associated with aging and OA in a mouse model.Methods: Murine knee cartilage DNA was extracted from healthy young (16‐week, n = 6), old (82‐week, n = 6), and young 4‐week post–destabilization of the medial meniscus (DMM) OA (n = 6) C57BL6/J mice. Genome‐wide DNA methylation patterns were determined via Illumina BeadChip. Gene set enrichment analysis was performed by Ingenuity Pathway Analysis. The top seven most differentially methylated positions (DMPs) were confirmed by pyrosequencing in an independent animal set. Results were compared to previously published human OA methylation data.Results: Aging was associated with 20,940 DMPs, whereas OA was associated with 761 DMPs. Merging these two conditions revealed 279 shared DMPs. All demonstrated similar directionality and magnitude of change (Δβ 1.0% ± 0.2%, mean methylation change ± SEM). Shared DMPs were enriched in OA‐associated pathways, including RhoA signaling (P = 1.57 × 10−4), protein kinase A signaling (P = 3.38 × 10−4), and NFAT signaling (P = 6.14 × 10−4). Upstream regulators, including TET3 (P = 6.15 × 10−4), immunoglobulin (P = 6.14 × 10−4), and TLR7 (P = 7.53 × 10−4), were also enriched. Pyrosequencing confirmed six of the seven top DMPs in an independent cohort.Conclusion: Aging and early OA following DMM surgery induce similar DNA methylation changes within a murine OA model, suggesting that aging may induce pro‐OA epigenetic “poising” within articular cartilage. Future research should focus on confirming and expanding these findings to other environmental OA risk factors, including obesity, as well as determining late OA changes in mice.

22 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CDChristopher Dunn
Christopher Dunn
CWCaleb Watkins
Caleb Watkins
GHGideon Hallum
Gideon Hallum
NPNathan Pezant
Nathan Pezant
ARAstrid Rasmussen
Astrid Rasmussen
CMCourtney Montgomery
Courtney Montgomery
Sarcoidosis is a heterogenous disease of unknown etiology characterized by non-caseating granulomas. Disease prevalence and presentation vary significantly by ancestry and ranges from acute, self-resolving disease to severe, chronic disease. Following previous reports suggesting B cells in the development and pathogenesis of sarcoidosis, we present here results of single-cell RNA sequencing, supporting B cell involvement in sarcoidosis through altered immediate early response, rewiring of MAPK signaling, and ancestry-specific preferential expansion of B cell receptors. Peripheral blood mononuclear cells were obtained from individuals of African or European Ancestry (AA and EA, respectively) including 48 healthy controls, 59 sarcoidosis patients, and 28 systemic lupus erythematosus (SLE) patients. SLE samples were used as a disease control. Differential expression analysis highlighted many differentially expressed genes (DEGs) with almost 5x more in the AA sarcoidosis versus AA control group compared to the EA sarcoidosis versus EA control group. B cells had the most DEGs of all cell types and expression patterns were similar between ancestries, however, sarcoidosis had an opposite transcription pattern than SLE, demonstrating an alternative immune response to acute activation than that seen in a prototypical autoinflammatory disease. This trend was maintained when examining specialized B cell subsets, with the most pronounced effect in the AA sarcoidosis versus AA control comparison. Our results strongly support further investigation of the role of humoral immune response in sarcoidosis and the potential to highlight patient groups likely to benefit from existing B cell therapies.